T1000	Negation 5621 5628	without
E1000	Negation:T1000 Scope:T1001
T1001	Span 5621 5652	without anti-CD3/28 stimulation
T1002	Negation 3644 3651	without
E1001	Negation:T1002 Scope:T1003
T1003	Span 3644 3671	without a current infection
T1004	Negation 6143 6145	no
E1002	Negation:T1004 Scope:T1005
T1005	Span 6143 6187	no T reg cells were added in a control group
T1006	Negation 6122 6129	without
E1003	Negation:T1006 Scope:T1007
T1007	Span 6122 6141	without suppression
T1008	Speculation 8870 8872	or
E1004	Speculation:T1008 Scope:T1009
T1009	Span 8864 8887	RUNX1 or RUNX3 fragment
T1010	Speculation 6753 6761	putative
E1005	Speculation:T1010 Scope:T1011
T1011	Span 6753 6809	putative RUNX binding sites in the FOXP3 promoter region
T1012	Speculation 15619 15621	or
E1006	Speculation:T1012 Scope:T1013
T1013	Span 15567 15668	the mutated or the wild-type binding sites was used or single oligonucleotides were used in the assay
T1014	Speculation 9635 9637	or
E1007	Speculation:T1014 Scope:T1015
T1015	Span 9635 9703	or were stimulated after 12 h with anti-CD2, anti-CD3, and anti-CD28
T1016	Negation 19736 19739	not
E1008	Negation:T1016 Scope:T1017
T1017	Span 19736 19829	not effect Foxp3 expression in naive CD4+ T cells of CbfbF/F CD4-cre and CbfbF/F control mice
T1018	Speculation 19486 19494	putative
E1009	Speculation:T1018 Scope:T1019
T1019	Span 19486 19513	putative RUNX binding sites
